Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Tamuzimod by Ventyx Biosciences for Ulcerative Colitis: Likelihood of Approval
Tamuzimod is under clinical development by Ventyx Biosciences and currently in Phase II for Ulcerative Colitis. According to GlobalData, Phase...